Parasitic worms are difficult to kill with current therapies, but their commensal bacteria might be their Achilles’ heel.

Aztreonam–avibactam is a promising treatment for complicated intra-abdominal infections and hospital-acquired or ...

The development of nanodrugs targeting multidrug-resistant bacteria, while sparing the beneficial constituents of the microbiome, has emerged as a promising approach to combat disease and curb the ...

Scientists discovered that gym equipment contains more bacteria than your toilet seat. The researchers collected samples from ...

Referral to an infectious disease physician was the only modifiable strategy to reduce 28-day mortality among adults presenting to the ED with bacteremia.

New research suggests that people with higher levels of a "good" bacteria in their guts also have lower levels of bacteria ...

Jason B. Pieper, DVM, MS, DACVD, talked about pyoderma, including ingredients and formulations, in his lecture at the 2025 ...

Antimicrobial resistance (AMR) has emerged as one of the leading public health threats globally, including South Africa ...

For Cresemba, this comprises a milestone payment for sales in Canada, by AVIR Pharma Inc, as well as the first sales milestone payment for the Middle East and North Africa (MENA) region, by Hikma ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial ...

National Institute of Virology has identified campylobacter bacteria—one of the leading causes of acute gastroenteritis—as a ...

BV100 is a new formulation of rifabutin suitable for intravenous administration, which BioVersys claims offers a new ...